View DividendEnsol Biosciences マネジメントマネジメント 基準チェック /04現在、CEO に関する十分な情報がありません。主要情報 最高経営責任者n/a報酬総額CEO給与比率n/aCEO在任期間no dataCEOの所有権n/a経営陣の平均在職期間データなし取締役会の平均在任期間データなし経営陣の近況Ensol Biosciences Inc., Annual General Meeting, Mar 29, 2021Mar 13すべての更新を表示Recent updatesNew minor risk - Shareholder dilution Nov 21Ensol Biosciences Inc. announced that it has received KRW 1.5 billion in funding from Samho Green Investment, Inc.Nov 16New major risk - Share price stability Sep 12Ensol Biosciences Inc. announced that it expects to receive KRW 1 billion in funding from MAGNA Investment Co., Ltd.Sep 11New major risk - Share price stability Jan 27Ensol Biosciences Inc. announced that it has received KRW 2.93 billion in funding from Gluon Bond Investment DayJun 11Ensol Biosciences Inc. announced that it has received KRW 2.93 billion in funding from Gluon Bond Investment DayJun 10Ensol Biosciences Inc. announced that it expects to receive KRW 5 billion in fundingApr 12Ensol Biosciences Inc., Annual General Meeting, Mar 29, 2021Mar 13New 90-day high: ₩22,250 Feb 26Ensol Biosciences Inc. announced that it has received KRW 3 billion in funding from Tiger Asset Management Discretionary Investment Co., Ltd.Feb 17Ensol Biosciences Inc. announced that it expects to receive KRW 3 billion in funding from Tiger Asset Management Discretionary Investment Co., Ltd.Feb 06New 90-day high: ₩19,050 Feb 01New 90-day high: ₩17,300 Jan 05New 90-day low: ₩13,700 Nov 20New 90-day high - ₩17,300 Sep 08New 90-day high - ₩12,450 Jul 17CEO（最高経営責任者Ensol Biosciences CEOがいない、あるいは彼らに関するデータがない。View Ownership
Ensol Biosciences Inc. announced that it has received KRW 1.5 billion in funding from Samho Green Investment, Inc.Nov 16
Ensol Biosciences Inc. announced that it expects to receive KRW 1 billion in funding from MAGNA Investment Co., Ltd.Sep 11
Ensol Biosciences Inc. announced that it has received KRW 2.93 billion in funding from Gluon Bond Investment DayJun 11
Ensol Biosciences Inc. announced that it has received KRW 2.93 billion in funding from Gluon Bond Investment DayJun 10
Ensol Biosciences Inc. announced that it has received KRW 3 billion in funding from Tiger Asset Management Discretionary Investment Co., Ltd.Feb 17
Ensol Biosciences Inc. announced that it expects to receive KRW 3 billion in funding from Tiger Asset Management Discretionary Investment Co., Ltd.Feb 06